Literature DB >> 19630796

Empirical and theoretical phenotypic discrimination.

K E Brummel-Ziedins1, T Orfeo, F R Rosendaal, A Undas, G E Rivard, S Butenas, K G Mann.   

Abstract

We have developed an integrated approach that combines empirical and computational methodologies to define an individual's thrombin phenotype. We have evaluated the process of thrombin generation in healthy individuals and individuals with defined pathologies in order to develop general criteria relevant to assess an individual's propensity for hemorrhage or thrombosis. Three complementary hypotheses have emerged from our work: (i) compensation by the ensemble of other coagulation proteins in individuals with specific factor deficiencies can 'normalize' an individual's thrombin generation process and represents a rationale for their unexpected phenotype; (ii) individuals with clinically unremarkable factor levels may present thrombin generation profiles typical of individuals with hemostatic complications; and (iii) in some hemostatic disorders a specific pattern of expression of a small ensemble of coagulation factors may be sufficient to explain the overall phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630796      PMCID: PMC3395063          DOI: 10.1111/j.1538-7836.2009.03426.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  42 in total

Review 1.  Phenotyping the haemostatic system by thrombography--potential for the estimation of thrombotic risk.

Authors:  Véronique Regnault; H Coenraad Hemker; Denis Wahl; Thomas Lecompte
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

2.  Blood clotting in minimally altered whole blood.

Authors:  M D Rand; J B Lock; C van't Veer; D P Gaffney; K G Mann
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

Review 3.  Coronary plaque disruption.

Authors:  E Falk; P K Shah; V Fuster
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

Review 4.  Hemophilia A.

Authors:  L W Hoyer
Journal:  N Engl J Med       Date:  1994-01-06       Impact factor: 91.245

5.  Molecular mechanism for familial protein C deficiency and thrombosis in protein CVermont (Glu20-->Ala and Val34-->Met).

Authors:  D Lu; E G Bovill; G L Long
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

Review 6.  Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Robert A Harrington; Richard C Becker; Michael Ezekowitz; Thomas W Meade; Christopher M O'Connor; David A Vorchheimer; Gordon H Guyatt
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

7.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

8.  Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B.

Authors:  A Ahlberg
Journal:  Acta Orthop Scand Suppl       Date:  1965

9.  Thrombin generation: phenotypic quantitation.

Authors:  K E Brummel-Ziedins; R L Pouliot; K G Mann
Journal:  J Thromb Haemost       Date:  2004-02       Impact factor: 5.824

10.  Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis.

Authors:  T Koster; A D Blann; E Briët; J P Vandenbroucke; F R Rosendaal
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

View more
  15 in total

1.  Is there value in kinetic modeling of thrombin generation? Yes.

Authors:  K G Mann
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

2.  Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.

Authors:  Alexander Y Mitrophanov; Alisa S Wolberg; Jaques Reifman
Journal:  Mol Biosyst       Date:  2014-07-29

3.  Real-time measurement of thrombin generation using continuous droplet microfluidics.

Authors:  Jiaqing Yu; Ding Tao; Ee Xing Ng; Chester L Drum; Ai Qun Liu; Chia-Hung Chen
Journal:  Biomicrofluidics       Date:  2014-09-03       Impact factor: 2.800

4.  Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events.

Authors:  Matthew Gissel; Anetta Undas; Agnieszka Slowik; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  Thromb Res       Date:  2010-08-14       Impact factor: 3.944

5.  Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Authors:  Jeffrey L Platt; Marilia Cascalho; Jorge A Piedrahita
Journal:  ILAR J       Date:  2018-12-31

Review 6.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

7.  Computational simulation and comparison of prothrombin complex concentrate dosing schemes for warfarin reversal in cardiac surgery.

Authors:  Kenichi A Tanaka; Michael A Mazzeffi; Erik R Strauss; Fania Szlam; Nina A Guzzetta
Journal:  J Anesth       Date:  2016-01-09       Impact factor: 2.078

Review 8.  Computationally Driven Discovery in Coagulation.

Authors:  Kathryn G Link; Michael T Stobb; Dougald M Monroe; Aaron L Fogelson; Keith B Neeves; Suzanne S Sindi; Karin Leiderman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

9.  Defining the boundaries of normal thrombin generation: investigations into hemostasis.

Authors:  Christopher M Danforth; Thomas Orfeo; Stephen J Everse; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

10.  From principle to practice: bridging the gap in patient profiling.

Authors:  Jonathan H Foley; Thomas Orfeo; Anetta Undas; Kelley C McLean; Ira M Bernstein; Georges-Etienne Rivard; Kenneth G Mann; Stephen J Everse; Kathleen E Brummel-Ziedins
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.